Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Eli Lilly and NYSE:LLY |
790,98 B | 23,56% | 6/6 | 34,75% | 14,23% | 42,54% | DOWN |
|
Johnson & Johnson NYSE:JNJ |
547,64 B | 5,26% | 5/5 | 7,04% | -23,99% | 13,85% | UP |
|
Merck NYSE:MRK |
276,38 B | 7,67% | 6/6 | -21,36% | -4,28% | 20,64% | UP |
|
Pfizer NYSE:PFE |
153,59 B | 7,82% | 4/6 | -5,31% | 21,68% | 3,70% | UP |
|
Bristol-Myers Squibb NYSE:BMY |
119,87 B | 1,77% | 5/6 | -0,30% | -0,96% | 9,01% | UP |
|
Vertex Pharmaceuticals NasdaqGS:VRTX |
109,50 B | 13,44% | 6/6 | 6,43% | 0,61% | 29,62% | DOWN |
|
Regeneron Pharmaceuticals NasdaqGS:REGN |
77,13 B | 9,26% | 5/6 | 5,41% | 4,64% | 17,42% | UP |
|
Zoetis NYSE:ZTS |
49,15 B | 9,80% | 6/6 | 7,18% | 47,84% | 24,07% | DOWN |
|
United Therapeutics NasdaqGS:UTHR |
24,86 B | 15,13% | 5/6 | 2,41% | -45,92% | 16,37% | UP |
|
Viatris NasdaqGS:VTRS |
16,99 B | -3,69% | 4/6 | 2,85% | -47,76% | 16,52% | UP |
|
Madrigal Pharmaceuticals NasdaqGS:MDGL |
11,75 B | 0,00% | 2/4 | 0,00% | 0,00% | 26,27% | UP |
|
Catalent NYSE:CTLT |
11,52 B | -5,82% | 2/6 | 27,69% | -22,42% | 0,03% | UP |
|
Cytokinetics NasdaqGS:CYTK |
8,12 B | -1,08% | 1/6 | 4,92% | -42,26% | 43,14% | UP |
|
Balchem NasdaqGS:BCPC |
5,57 B | 8,75% | 6/6 | 8,46% | 1,11% | 16,53% | UP |
|
TG Therapeutics NasdaqCM:TGTX |
5,41 B | 63,45% | 3/5 | 33,54% | 92,56% | 25,61% | UP |
|
Indivior Pharmaceuticals NasdaqGS:INDV |
4,04 B | 28,91% | 5/6 | 13,62% | -7,94% | 7,18% | UP |
|
Ligand Pharmaceuticals NasdaqGM:LGND |
4,61 B | 7,83% | 5/6 | 3,60% | -70,53% | 6,59% | UP |
|
Nektar Therapeutics NasdaqCM:NKTR |
3,09 B | 65,15% | 4/6 | 74,02% | -560,36% | 63,61% | UP |
|
Supernus Pharmaceuticals NasdaqGM:SUPN |
2,87 B | 2,48% | 3/6 | 8,61% | -26,78% | 30,63% | UP |
|
Soleno Therapeutics NasdaqCM:SLNO |
2,73 B | 0,00% | 3/4 | 0,00% | 0,00% | 0,53% | UP |
